Danish police are investigating Novo Nordisk ( NVO -0.5% ) after the company waited two days to disclose that the FDA had declined to approve diabetes treatment Tresiba, the
disappointing sales and was linked to a potential risk of lung cancer in former smokers, causing diabetes experts such as Novo Nordisk NVO and Eli Lilly LLY to withdraw their own inhaled insulin products from late-stage trials. Although MannKind plans to remedy
Novo Nordisk ( NVO ) is set to initiate a Phase 2 study of oral Victoza . "It is a ..... t be easy, Thomsen says "the data [he has] so far suggests [ NVO ] can do it." NVO is looking to get the oral version to market within five to six years
By Sharon di Stefano : Clinical interest in oral insulin, estimated to have market potential upwards of $10 billion, is escalating as more diabetics are diagnosed each year and patients' petulant demands for an alternative to needles and pens use up more of a doctor's limited practice time. Not ...
The FDA approves Novo Nordisk's ( NVO ) NovoRapid FlexTouch and Levemir FlexTouch prefilled insulin pens. The company plans to make the pens available in the U.S. "within the next year." ( PR ) Post your comment!
Novo Nordisk A/S ( NVO ) Q3 2013 Earnings Call November 01, 2013 8:30 am ET Executives Jesper Brandgaard - Chief Financial Officer, Executive Vice
Novo Nordisk A/S ( NVO ) Q3 2013 Earnings Call October 31, 2013 8:00 am ET Executives Lars Rebien Sørensen - Chief Executive Officer, President and
Complete Story »
Novo Nordisk's ( NVO ) Q3 net profit increased 13% to 6.42B ($1.18B) Danish kroner but missed estimates of DKK6.52B. Sales rose 3.4% to
IRM , ITC , ITT , IVZ , KEM , LECO , LIOX , LKQ , MA , MGM , MMP , MOD , MPC , MPLX , MSCI , MYL , NI , NIHD , NILE , NMM , NVO , NYT , O , OCN , OSK , PDCE , PNW , PPL , PRGO , PRLB , PWR , Q , RFP , SCG , SFY , SHOO , SMP , SNAK , SNE , STRA , TDC , TE